.svg){kind=icon}
Dovramilast for leprosy type 2 reaction
Developing a new Treatment for Leprosy Type 2 Reaction. A new treatment with the potential to alleviate suffering, improve outcomes and ensure patients have access to this much needed medicine.
Developing a new Treatment for Leprosy Type 2 Reaction. A new treatment with the potential to alleviate suffering, improve outcomes and ensure patients have access to this much needed medicine.
Stay up to date
Follow our work by signing up for our newsletter
Medicines Development for Global Health acknowledges the sovereignty of the Peoples of the Boon Warrung/Woj Wurrung clan(s) of the Kulin nation of the land on which MDGH’s headquarters stand, and we pay our respects to their ancestors and Elders. We are here to achieve greater equity of access to good health globally, through the development of medicines for the treatment of neglected diseases, whilst respecting the right to self-determination of First Peoples everywhere.
Medicines Development for Global Health Limited.
Level 1, 18 Kavanagh Street Southbank Victoria 3006 Australia.
ABN: 79 116 977 523